Annual Drug Patent Expirations for DORYX
Doryx is a drug marketed by Mayne Pharma Intl, Warner Chilcott, and Mayne Pharma and, and is included in three NDAs. It is available from two suppliers. There are five patents protecting this drug and seven Paragraph IV challenges.
Drug patent litigation for DORYX.
This drug has two patent family members in two countries.
The generic ingredient in DORYX is doxycycline hyclate. Two suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com